Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Popovits Kimberly J, Director. Director active across 4 companies, notably 10x Genomics, Inc.. Cumulatively, 11 filings have been recorded. Breakdown: 0 buy · 1 sell. Activity tracked since 11 June 2021. The latest transaction was disclosed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
11 of 11 declarations
Kimberly J. Popovits is a Board Member at 10x Genomics, Inc. In this role, she oversees operations and contributes to the strategic direction of the company. Her experience in the biopharmaceutical sector allows her to provide valuable insights for the company's development.